ARTICLE | Clinical News
Anti-cancer immunotherapy: Phase I/II started
May 5, 2008 7:00 AM UTC
Quantum began an open-label, U.S. Phase I/II trial to evaluate 3 doses of the vaccine immunotherapy given every 2-3 weeks in 25 patients who have not responded to traditional therapies. The immunizing...